December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Rami Manochakian: Results of adjuvant Alectinib vs Chemotherapy in resected ALK+ stage IB-IIIA NSCLC
Apr 13, 2024, 09:40

Rami Manochakian: Results of adjuvant Alectinib vs Chemotherapy in resected ALK+ stage IB-IIIA NSCLC

Rami Manochakian, thoracic medical oncologist at Mayo Clinic, shared a post on X:

Hot off the press.
Just published at
NEJM.
Results of ALINA phase 3 trial of adjuvant Alectinib vs Chemotherapy in patients with resected ALK+ stage IB-IIIA Non-Small-Cell Lung Cancer showing: DFS HR: 0.24
2-year DFS: 93% vs 63%

Source: Rami Manochakian/X